← Leaderboards
Wyatt Daniel Unger
Microvascular Therapeutics, Llc
$2,078,893
Attributed
$2,885,860
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,885,860 · 4
By mechanism
R44$1,613,934 · 1
R43$773,696 · 2
SB1$498,230 · 1
Top collaborators
- Thomas R Porter2 shared
Others in their field
Other Emerging Leaders on “Microbubbles”
- Hong Chen · Washington University$13,007,379
- Misun Hwang · Children'S Hosp Of Philadelphia$5,345,995
- Kibo Nam · Thomas Jefferson University$3,822,520
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$3,282,845
- Wei-Chuan Shih · University Of Houston$3,052,798
- Junjie Yao · Brigham And Women'S Hospital$2,942,019
Research focus
MicrobubblesTheranosticsUltrasonographyLegal PatentPathway InteractionsDefinityContrast MediaMolecular ImagingTemperatureImageLabelProgramsElectrostaticsProductionOptisonAlzheimer&AposSmall Business Innovation Research GrantLeadChargeInfusion ProceduresEchocardiographyBack PainDoseDesign
Grant awards (6)
MVT-100 Manufacturing and Commercialization.$206,081
SB1 · FY2023 · HL · contact PI
MVT-100 Manufacturing and Commercialization.$292,149
SB1 · FY2022 · HL · contact PI
Targeted ultrasound contrast agents for the disruption of Alzheimer's plaques.$395,506
R43 · FY2020 · AG · contact PI
Ultrasound-Stimulated Phase-Change Contrast Agents for Sonothrombolysis.$378,190
R43 · FY2020 · HL · contact PI
Development of New Improved Perflutren Ultrasound Contrast Agent$384,549
R44 · FY2019 · HL · contact PI
Development of New Improved Perflutren Ultrasound Contrast Agent$1,229,385
R44 · FY2017 · HL · contact PI